Atlas Trials

Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

Clinical trial NCT02315287 · UNKNOWN

Trial details

NCT number
NCT02315287
Sponsor
Seoul National University Bundang Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2014-09-01
Primary completion
2021-12-31
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.